India is battling a silent but deadly epidemic — the spread of counterfeit medicines and consumer goods. The recent cough syrup tragedy has forced an in-depth investigation, exposing deep weaknesses within the regulatory system. Between 2023 and 2025, multiple incidents of fake or contaminated drugs were discovered, yet most culprits faced little or no punishment.

In Gujarat, officials uncovered a factory in Kutch producing fake Colgate toothpaste made from “cheap and substandard” materials, along with counterfeit Sensodyne, Eno, and even cigarettes. In August 2025, the Uttar Pradesh Food Safety & Drugs Department and the STF (Special Task Force) carried out large-scale raids in Agra and Lucknow, seizing counterfeit medicines worth over ₹200 crore. Several shop owners were arrested after it was revealed that a network was importing fake medicines from Chennai and Puducherry and selling them as trusted brands for diabetes, pain relief, colds, and coughs. One Agra trader even tried to bribe officers with ₹1 crore to delay the investigation.

During a 60-hour police operation in Kanpur, two secret factories were found manufacturing 434 varieties of fake drugs worth around ₹4.5 crore. Investigators discovered computer records showing sales across India and even exports to Africa and Afghanistan to hide the trail.

Punjab also faced health scares when patients fell ill after receiving tainted intravenous fluids. In mid-October 2025, the Health Department banned eight IV fluids — including batches of normal saline, dextrose 5%, ciprofloxacin, and a bupivacaine–dextrose mix — following reports of severe adverse reactions. All hospitals were ordered to stop using the suspicious stock immediately. Shockingly, the recalled products carried the names of reputed companies. The Health Minister of Punjab announced an inquiry and promised strong action against those involved.

In Rajasthan, the problem was equally alarming. According to an India Today report (October 2025), hundreds of prescription samples — including antibiotics like amoxicillin and ciprofloxacin, diabetic medicines, antihistamines, and painkillers — failed quality tests. Many of these counterfeit or low-quality medicines had already been sold to patients before the discovery, creating a serious health hazard.

Fatal Consequences: The Hidden Dangers of Fake Drugs

Counterfeit products are not just fraudulent — they can be deadly. Experts warn that such medicines often contain harmful chemicals or wrong dosages, putting patients’ lives at risk. For example, fake Eno powders can cause allergic reactions, internal bleeding, or ulcers, while false antibiotics and painkillers may have no active ingredients at all, allowing infections to worsen and organs to fail.

Health experts call these items “slow poisons.” Contaminated toothpaste erodes gums and teeth, fake cigarettes carry toxic compounds, and adulterated masalas may contain cancer-causing agents.

The situation in Rajasthan is especially disturbing — hundreds of children may have unknowingly consumed fake medicines before the authorities intervened. The problem is not confined to India. In 2022, contaminated cough syrups made in India caused the deaths of 70 children in The Gambia and 19 in Uzbekistan, prompting international outrage. The World Health Organization (WHO) investigated and found “unacceptable levels of diethylene glycol and ethylene glycol” in the syrups — chemicals known to cause kidney failure and death in children.

The WHO’s findings triggered a global alarm and forced importing nations to recheck their pharmaceutical supplies. In India, regulators tightened inspections of syrup manufacturers and promised stricter quality controls. The tragedy underlined a harsh truth: “when quality control fails in one country, lives are lost everywhere.”

In early 2025, Punjab once again had to recall contaminated batches of Ringer’s lactate and saline after patients fell sick. Frustrated doctors voiced their concern, saying, “patient care goes for a toss if we can’t ensure the quality of basic IV fluids.”

Staying Alert: Protecting Yourself from Counterfeits

Consumers are the first line of defense. Any deal that appears too cheap should be treated with suspicion. Always buy medicines from authorised pharmacies or reliable online sellers. Genuine packaging usually carries batch numbers, expiry dates, and QR or scratch codes to confirm authenticity. Officials warn citizens to “buy products from authorised sellers and verify packaging details for authenticity before use.”

Check for certified logos and complete manufacturer details on common goods such as toothpaste or masalas. Report anything suspicious to drug control offices or consumer helplines — several states, including Haryana, have launched dedicated complaint hotlines. In emergencies, insist on hospital-issued drugs that have already passed quality checks, and if unsure, verify with the pharmacist.

Stronger Action: How India is Responding

Following these repeated incidents, the government has intensified its crackdown. The Union Health Ministry has suspended and revoked licences of companies found negligent. In March 2023, Health Minister Mansukh Mandaviya assured that firms making fake medicines “will not be spared.” After WHO linked Indian cough syrups to child deaths, the Centre allocated $80 million to modernise drug-testing laboratories and strengthen nationwide inspections.

The Central Drugs Standard Control Organisation (CDSCO) is drafting new laws to make distributors and chemists legally accountable for selling or storing counterfeit medicines. If approved, even retailers holding fake stock — knowingly or not — could face prosecution. Every link in the supply chain would have to prove its quality checks to avoid punishment.

Authorities are also preparing to make unique scannable QR codes mandatory on all medicines, especially antibiotics and syrups, connecting them to a national registry for instant verification. Manufacturers, importers, and hospitals will have to scan and record the codes on receipt.

Other proposals include expanding mobile testing labs in rural districts, categorising deliberate mislabelling as a non-bailable criminal offence, and using an upgraded pharmacovigilance network to trace faulty batches quickly. Health experts also suggest training medical staff to verify packaging and document batch details to ensure accountability from supplier to patient.

Public education remains crucial. The government plans to use television and social media to warn people about fake online pharmacies and delivery services that sell medicines without prescriptions. Coordination between customs, police, and drug authorities is being strengthened to break cross-border smuggling networks — as seen in the recent joint STF and Drug Department raids in Uttar Pradesh.

A Nation at the Crossroads: Restoring Faith in Indian Medicine

The rise in fake drugs and consumer goods like phoney toothpaste and masalas has shaken public trust. Experts warn that counterfeit medicines will continue to circulate “under the radar” unless authorities enforce harsh penalties and consistent inspections. Raids have become more frequent, and new policies are taking shape, but maintaining vigilance is essential for lasting change.

India has earned global respect as a centre for affordable healthcare, vaccines, and advanced therapies, attracting medical tourists from around the world. However, this reputation carries responsibility. Regulators, manufacturers, and suppliers must ensure transparency, quality, and honesty throughout the supply chain.

By expanding drug testing, enforcing serialisation, and promoting consumer awareness, India can continue to deliver safe, high-quality medicines both domestically and internationally. Only through strict regulation and public vigilance can the nation safeguard its people — ensuring that every tablet, syrup, or injection in an Indian pharmacy is genuine, effective, and life-saving, not a silent killer disguised in trust.